Rare disease medicine commercialisation
The company seeks to in-license and acquire rare disease medicines in late-stage clinical development.
Source: LinkedIn company description · Retrieved October 13, 2026
Oranda Therapeutics is a rare disease company focused on acquiring, developing and commercialising medicines for areas of high unmet need.
The company has a portfolio of established rare disease medicines and is building a rare disease commercialisation platform. Its team has BioPharma expertise in late-stage development, product licensing and commercialisation.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company seeks to in-license and acquire rare disease medicines in late-stage clinical development.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026 and September 20, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.